Workshop, 5-6 Sept 2017
Microfluidic particle fractionation based on the inherent properties of e.g. cells, microorganisms and organelles offers significant improvements over conventional techniques in terms of ease of handling and usage, speed and reductions in cost. We consolidated the field at the European level and created a unique comprehensive training program that rested on solid experimental and theoretical foundations.
LAPASO provided a unique training opportunity for 15 fellows in a highly interdisciplinary and intersectorial environment with the overarching scientific objective of advancing diagnostics for a wide range of critical medical conditions using advanced microfluidics and nanobiotechnology integration.
The project was funded by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement n° 607350. The project started on 1 October 2013 and ended on 30 September 2017.
The publishable part of the Final Report can be downloaded as pdf: Download Final Report
Prof. Mehmet Toner, Harvard University, USA
Prof. Jochen Guck, TU Dresden, Germany
Dr. Veerle Lejon, Institute of Research for Development, Montpellier, France
Prof. Michael Barrett, Glasgow University, UK
Dr. Mark Sutton, Public Health England, UK
Prof. Henrik Bruus, DTU, Denmark
Microfluidic label-free particle fractionation based on the inherent properties of
particles (e.g. cells, microorganisms, organelles) offers significant advantages over conventional techniques in terms of ease of
handling and usage, speed, and reduction in cost. We aim here to utilise our comprehensive network and solid experience to put to
use several microfluidics technologies to address important biomedical problems.
This workshop has three interdisciplinary and inter-related themes based on understanding and exploiting label-free particle analysis:
|Parasites – improve diagnosis by enriching parasites that occur at low concentrations;|
|Bacteria: sorting of bacteria in different subpopulations based on morphology that is connected to pathogenicity;|
|Rare cells: enrich rare stem cells for therapeutic use;|
To tackle these challenges we will cover a wide range of technologies such as:
|Materials, processing and simulation of micro- and nanosystem components|
|Integrated optics and electronics|
Oral presentations were given by invited international experts, researchers, successful entrepreneurs,
and experienced industry people.
Poster sessions were held in connection to the presentations where researchers and companies presented their scientific work in the respective areas.
BergmanLabora AB is one of Sweden’s leading suppliers of analytical instruments, microscopy products and apparatus for laboratories. Our core values simplicity, efficiency, change, freedom and responsibility are leading us in everything we do.
We have more than 100 Years of experience, supplying laboratories with products and solutions from world leading suppliers together with knowledge, service and support.
Through the knowledge and local presence, with a great amount of simplicity, flexibility and personality we help our customers to succeed.
Hamamatsu is a world leader in optoelectronics. We offer the widest product range of components, modules and systems on the market for science and research and for a broad range of applications within medicine, biotechnology, industry, automation and consumer electronics. Our worldwide organisation with headquarter in Japan has sales and technical support offices around the world. Hamamatsu Photonics Norden AB is supporting our customers in the Nordic and Baltic countries, Russia and CIS.
Jonas Tegenfeldt, Lund University
Hywel Morgan, University of Southampton
Lisa Ranford-Cartwright, University of Glasgow
Michael Barrett, University of Glasgow
Birgitta Henriques-Normark, Karolinska Institutet
Thomas Laurell, Lund University
Jochen Guck, TU Dresden
Gerhard Gompper, FZ Juelich
© Stefan Holm 2014, last updated January 2019